Natural Products Research Strategies
Cell-based/in vitro: Testing of mechanisms of action in panels of cellular and/or enzymatic assays |
||||||
Antioxidant
|
Anti-
|
Immuno-
|
Vascular |
Pain
|
||
CAP-e (Cell-based Antioxidant Protection using Erythroctyes |
X |
|||||
CAP-m (Cell-based Antioxidant Protection of Mitochondria) |
X |
|||||
CAP-a (Cell-based Antioxidant Protection against Apoptosis) |
X |
|||||
Inhibition/Support of Production of Reactive Oxygen Species |
X |
X |
||||
Phagocytosis |
X |
|||||
PMN migration (immune surveillance/
antibacterial/
|
X |
X |
||||
PMN migration (immune surveillance/anti-allergic effects) |
X |
X |
||||
Lymphocyte Proliferation Assay 1: Basic Testing |
|
X |
||||
Lymphocyte Proliferation Assay 2: Advanced |
|
X |
||||
T/B Lymphocyte Activation: Phenotyping |
|
X |
||||
Cytokine Production |
|
X |
||||
Natural Killer Cell Activation: Basic Testing |
X |
|||||
Natural Killer Cell Activation: Advanced |
X |
|||||
Inhibition of COX-2 gene expression |
X |
|||||
Inhibition of COX-2, Lipoxygenase enzymatic function |
X |
|||||
| Click here for Clinical/In vivo Tests | ||||||